secwatch / observer
8-K filed March 16, 2023, 7:59 PM ET ticker BLND CIK 0001855747
earnings confidence high sentiment negative materiality 0.75

Blend Labs Q4 revenue $42.8M, FY2022 rev $235.2M; President resigns; guides Q1 rev $33-35M

Blend Labs, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Timothy Mayopoulos

President
BLND · Blend Labs, Inc.
Effective
2023-03-13
Filed
March 16, 2023, 7:59 PM ET
On March 13, 2023, Mr. Mayopoulos resigned as President of the Company, effective immediately, to pursue other professional opportunities.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Blend Labs, Inc. reported the fourth fiscal quarter and the full fiscal year ended December 31, 2022 results: revenue Consolidated 2022 revenue of $235.2 million, 4Q22 revenue of $42.8 million. Guidance reaffirmed.

Period
the fourth fiscal quarter and the full fiscal year ended December 31, 2022
Revenue
Consolidated 2022 revenue of $235.2 million, 4Q22 revenue of $42.8 million
Guidance
reaffirmed
Result
reported results
Exact text from the filing
Blend Labs, Inc. (the “Company” or “Blend”) issued a press release announcing its financial results for the fourth fiscal quarter and the full fiscal year ended December 31, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Timothy Mayopoulos resigned as President at Blend Labs, Inc..

Action
resigned
Role
President
Exact text from the filing
On March 13, 2023, Mr. Mayopoulos resigned as President of the Company, effective immediately, to pursue other professional opportunities.
View on SEC.gov

Browse all earnings releases →

Blend Labs, Inc. filing history →

Source: SEC EDGAR
accession 0001855747-23-000015
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.